Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial
Top Cited Papers
Open Access
- 4 July 2017
- journal article
- research article
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 140 (4), 1024-1031.e14
- https://doi.org/10.1016/j.jaci.2017.05.044
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Mepolizumab, a humanized anti–IL-5 mAb, as a treatment option for severe nasal polyposisJournal of Allergy and Clinical Immunology, 2011
- Chronic rhinosinusitis in Europe - an underestimated disease. A GA2LEN studyAllergy, 2011
- Cost Burden of Chronic RhinosinusitisOtolaryngology -- Head and Neck Surgery, 2011
- Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthmaJournal of Allergy and Clinical Immunology, 2010
- Oral steroids and doxycycline: Two different approaches to treat nasal polypsJournal of Allergy and Clinical Immunology, 2010
- Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus diseaseJournal of Allergy and Clinical Immunology, 2008
- Adrenal suppression and osteoporosis after treatment of nasal polyposisActa Oto-Laryngologica, 2006
- Nasal polyposis and its impact on quality of life: comparison between the effects of medical and surgical treatmentsAllergy, 2005
- Total and specific IgE in nasal polyps is related to local eosinophilic inflammationJournal of Allergy and Clinical Immunology, 2001
- GM‐CSF, IL‐5 and RANTES immunoreactivity and mRNA expression in chronic hyperplastic sinusitis with nasal polyposis (NP)Clinical and Experimental Allergy, 1998